Pixee Medical announced the world’s first shoulder implant surgery using mixed reality guidance through Shoulder+ technology.
Shoulder+ introduces a navigation tool tailored for primary Total Shoulder Replacement. This software, integrated into MS HoloLens 2 Mixed Reality Glasses, supports surgeons by delivering precise real-time information regarding the 3D positioning of the implant directly within their field of view. This guidance is made possible through 3D tracking of surgical instruments, driven by Pixee’s proprietary algorithms.
Notably, this solution offers an unparalleled see-through capability, enabling surgeons to see the bones through the skin during minimally invasive surgeries and to enhance operational precision.
Improving the accuracy contributes to a reduced risk of revision, improved joint function and decreased postoperative pain.
Shoulder+ has achieved approval under the CE Mark and has a pending FDA 510(k) clearance. This product expands Pixee’s portfolio to encompass a new joint, and also introduces a new visualization platform. The company will commence a limited release phase followed by worldwide launch with a strong emphasis on Europe, the United States and Asia.
Pixee Medical announced the world’s first shoulder implant surgery using mixed reality guidance through Shoulder+ technology.
Shoulder+ introduces a navigation tool tailored for primary Total Shoulder Replacement. This software, integrated into MS HoloLens 2 Mixed Reality Glasses, supports surgeons by delivering precise real-time information...
Pixee Medical announced the world’s first shoulder implant surgery using mixed reality guidance through Shoulder+ technology.
Shoulder+ introduces a navigation tool tailored for primary Total Shoulder Replacement. This software, integrated into MS HoloLens 2 Mixed Reality Glasses, supports surgeons by delivering precise real-time information regarding the 3D positioning of the implant directly within their field of view. This guidance is made possible through 3D tracking of surgical instruments, driven by Pixee’s proprietary algorithms.
Notably, this solution offers an unparalleled see-through capability, enabling surgeons to see the bones through the skin during minimally invasive surgeries and to enhance operational precision.
Improving the accuracy contributes to a reduced risk of revision, improved joint function and decreased postoperative pain.
Shoulder+ has achieved approval under the CE Mark and has a pending FDA 510(k) clearance. This product expands Pixee’s portfolio to encompass a new joint, and also introduces a new visualization platform. The company will commence a limited release phase followed by worldwide launch with a strong emphasis on Europe, the United States and Asia.
Copy to clipboard 
